Slc22a2-flox 基因敲除小鼠

1. Chen, Jiayin, Wang, Li, Tong, Gangling, Liu, Chaoran, Wang, Lijun. . The SLC22A2 gene is a determinant of hematological toxicity of oxaliplatin in patients with colorectal cancer. In International journal of clinical pharmacology and therapeutics, 61, 1-7. doi:10.5414/CP204156. https://pubmed.ncbi.nlm.nih.gov/36331012/

2. Li, Qing, Liu, Fang, Zheng, Tai-shan, Lu, Hui-juan, Jia, Wei-ping. . SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin. In Acta pharmacologica Sinica, 31, 184-90. doi:10.1038/aps.2009.189. https://pubmed.ncbi.nlm.nih.gov/20139901/

3. Borghetti, A, Calcagno, A, Lombardi, F, Bonora, S, Di Giambenedetto, S. . SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV. In The Journal of antimicrobial chemotherapy, 74, 1035-1043. doi:10.1093/jac/dky508. https://pubmed.ncbi.nlm.nih.gov/30561642/

4. Zhang, Jing, Zhou, Wen. 2012. Ameliorative effects of SLC22A2 gene polymorphism 808 G/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients. In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 50, 2289-93. doi:10.1016/j.fct.2012.03.077. https://pubmed.ncbi.nlm.nih.gov/22525860/